Prestige Consumer Healthcare Inc. PBV.F Stock
Prestige Consumer Healthcare Inc. Price Chart
Prestige Consumer Healthcare Inc. PBV.F Financial and Trading Overview
Prestige Consumer Healthcare Inc. stock price | 59.5 EUR |
Previous Close | 53 EUR |
Open | 52 EUR |
Bid | 52 EUR x 20000 |
Ask | 52.5 EUR x 20000 |
Day's Range | 52 - 52 EUR |
52 Week Range | 50 - 62.5 EUR |
Volume | 205 EUR |
Avg. Volume | 0 EUR |
Market Cap | 2.59B EUR |
Beta (5Y Monthly) | 0.554225 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 3.89 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | September 27, 2018 |
1y Target Est | 63.5 EUR |
PBV.F Valuation Measures
Enterprise Value | 3.94B EUR |
Trailing P/E | N/A |
Forward P/E | 12.235294 |
PEG Ratio (5 yr expected) | 3.63 |
Price/Sales (ttm) | 2.2969453 |
Price/Book (mrq) | 1.785653 |
Enterprise Value/Revenue | 3.496 |
Enterprise Value/EBITDA | 10.363 |
Trading Information
Prestige Consumer Healthcare Inc. Stock Price History
Beta (5Y Monthly) | 0.554225 |
52-Week Change | 1.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 62.5 EUR |
52 Week Low | 50 EUR |
50-Day Moving Average | 55.47 EUR |
200-Day Moving Average | 55.86 EUR |
PBV.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 49.69M |
Float | 49.36M |
Short Ratio | N/A |
% Held by Insiders | 0.82% |
% Held by Institutions | 102.62% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | -7.29% |
Operating Margin (ttm) | 30.84% |
Gross Margin | 56.11% |
EBITDA Margin | 33.73% |
Management Effectiveness
Return on Assets (ttm) | 6.18% |
Return on Equity (ttm) | -5.44% |
Income Statement
Revenue (ttm) | 1.13B EUR |
Revenue Per Share (ttm) | 22.61 EUR |
Quarterly Revenue Growth (yoy) | 7.09% |
Gross Profit (ttm) | N/A |
EBITDA | 380.43M EUR |
Net Income Avi to Common (ttm) | -82306000 EUR |
Diluted EPS (ttm) | -1.54 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 58.49M EUR |
Total Cash Per Share (mrq) | 1.18 EUR |
Total Debt (mrq) | 1.37B EUR |
Total Debt/Equity (mrq) | 94.47 EUR |
Current Ratio (mrq) | 2.438 |
Book Value Per Share (mrq) | 29.121 |
Cash Flow Statement
Operating Cash Flow (ttm) | 229.72M EUR |
Levered Free Cash Flow (ttm) | 165.23M EUR |
Profile of Prestige Consumer Healthcare Inc.
Country | Germany |
State | NY |
City | Tarrytown |
Address | 660 White Plains Road |
ZIP | 10591 |
Phone | 914 524 6800 |
Website | https://www.prestigebrands.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 560 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Q&A For Prestige Consumer Healthcare Inc. Stock
What is a current PBV.F stock price?
Prestige Consumer Healthcare Inc. PBV.F stock price today per share is 59.5 EUR.
How to purchase Prestige Consumer Healthcare Inc. stock?
You can buy PBV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prestige Consumer Healthcare Inc.?
The stock symbol or ticker of Prestige Consumer Healthcare Inc. is PBV.F.
Which industry does the Prestige Consumer Healthcare Inc. company belong to?
The Prestige Consumer Healthcare Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Prestige Consumer Healthcare Inc. have in circulation?
The max supply of Prestige Consumer Healthcare Inc. shares is 50.19M.
What is Prestige Consumer Healthcare Inc. Price to Earnings Ratio (PE Ratio)?
Prestige Consumer Healthcare Inc. PE Ratio is 15.29562950 now.
What was Prestige Consumer Healthcare Inc. earnings per share over the trailing 12 months (TTM)?
Prestige Consumer Healthcare Inc. EPS is 3.89 EUR over the trailing 12 months.
Which sector does the Prestige Consumer Healthcare Inc. company belong to?
The Prestige Consumer Healthcare Inc. sector is Healthcare.